ZIPHANOL
Therapeutic Indication
Moderate to severe pain of any form, particularly visceral pain; perioperative analgesia.
Dosage Forms
Soln for inj (amp) 2 mg/mL x 1 mL x 10’s.
Bioavailability and Pharmacokinetics
Opioids are readily absorbed after subcutaneous or intramuscular injection from the GI tract. A nasal formulation is available and has proven to be effective. The major pathway for the metabolism is conjugation with glucuronic acid. Very little of butorphanol is excreted unchanged. It is eliminated by glomerular filtration, 90% of the total excretion takes place during the first day.
The plasma half-life of butorphanol is about 3hrs. The usual dose is between 1 and 4mg of the tartrate given intramuscularly, or 0.5-2mg given intravenously every 3-4hrs.
Dose Range
IV 1 mg as single dose. May be repeated 3-4 hrly. Effective dose range: 0.5-2 mg repeated 3-4 hrly. IM 2 mg as single dose. May be repeated 3-4 hrly. Effective dose range: 1-4 mg repeated 3-4 hrly. Pre-op/pre-anesth/post-op medication 2 mg IM given 60-90 min prior to surgery. Balanced anesth 2 mg IV shortly before induction &/or 0.5-1 mg IV in increments during anesth. Labor 1-2 mg IV/IM & may be repeated after 4 hr.
Drug Interactions
Somnolence, dizziness, nausea, vomiting.
Special Precautions
Hepatic or renal disease; history of drug abuse; presence of abnormal fetal heart rate pattern during labor. Concomitant use w/ alcohol. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn <18 yr. Elderly >65 yr.
Check out our available products
PROPIX
Dosage Form & Strength Pharmacological Classification Therapeutic Indication Dosage and Administration Dosage Form & Strength 40 mg Lyophilized Powder for Injection (IV) Pharmacological Classification Omeprazole belongs to a class of antisecretory compounds,...
ZIROLAC
Therapeutic Indication Dosage Forms Bioavailability and Pharmacokinetics Dosage Range Known Adverse Effects and Toxicities Special Precautions Therapeutic Indication Therapeutic Indication Short-term management of moderately severe, acute pain at the opioid level. Dosage...
K5 CRYOLASER
PACKAGE SIZE & TYPE COMPOSITION DESCRIPTION INDICATION SUGGESTED USE CAUTION PACKAGE SIZE & TYPE 20 ml Tube COMPOSITION Dicaprylyl Ether, C12-15 Alkyl Benzoate, Cyclopentasiloxane, Zea mays (Corn) Starch, Pidobenzone, Ethylhexyl Methoxycinnamate (Octyl...
Get In Touch
For questions, inquiry or to know more about our products, please feel free to call us at +63 052 742-2844 / +63 02 829-0181, email us at zyrepharma@yahoo.com or click the button below.
Contact Us